Abstract Purpose of Review With the expanded roll-out of antiretrovirals for treatment and
prevention of HIV during the last decade, the emergence of HIV drug resistance (HIVDR) …

BACKGROUND: Given the elevated potential for primary or transmitted drug resistance
(TDR) among newly HIV-infected individuals, there is a need for a deeper understanding of …

The purpose of this article is to review prominent studies on HIV drug-resistance in mothers
and their infants after the use of antiretroviral drugs to prevent mother-to-child-transmission …

Here, we summarize the discussions and conclusions from an expert workshop held in
October 2012 to consider the implications of HIV drug resistance in the context of scale-up of …

In the USA and West Europe, nearly 80% of HIV‐1‐infected adults, experiencing virologic
failure, harbored virus strain resistant to at least one antiretroviral drug. Limited data are …

Objectives: The objectives of this study were to determine HIV drug resistance (HIVDR)
prevalence in Zambian infants upon diagnosis, and to determine how changing prevention …

Antiretroviral therapy (ART) is recommended for all people infected with human
immunodeficiency virus (HIV). The importance of wide population coverage and effective …

Transmission of HIV viruses harboring resistance mutations is already a major concern in
developed countries, with the potential to impact on therapeutic strategies. Several factors …

Children living with human immunodeficiency virus (HIV) in low-and middle-income
countries (LMICs) experience higher rates of virologic failure than adults. Human …

Barriers to sustainable virologic suppression (VS) of HIV-infected adolescents and young
adults include drug resistance mutations (DRMs) and limited treatment options, which may …